Results 201 to 210 of about 3,327,559 (283)

A review of xenobiotic membrane transporter expression within the human placenta: Lessons gained from primary tissue and in vitro methodologies

The Journal of Physiology, EarlyView.
Abstract figure legend A summary of the current knowledge around membrane transporter expression in the most widely used in vitro models of human trophoblasts, including primary placental tissue, cancer cell lines and trophoblast stem cells, as well as the techniques to attempt to mimic the human placenta in vivo.
Rhiannon Pass, Kathryn Wolton, Amanda N. Sferruzzi‐Perri   +2 more
wiley   +1 more source

Strategies for prevention, early detection and management of penile and testicular cancer in primary healthcare: scoping review protocol. [PDF]

BMJ Open
Sant'Ana RSE, de Matos WDV, Amaral JBDA, Calleja S, Maheu C, Hart NH, Rabelo AL, Sousa AR.   +7 more
europepmc   +1 more source

Comparison of Relapse Risk Prediction Models During Active Surveillance in Stage I Seminoma: A Retrospective Multicenter Cohort Study

International Journal of Cancer, Volume 159, Issue 12, Page 3008-3015, 15 December 2026.
ABSTRACT To improve the prediction of relapse for clinical stage I seminoma, we aimed to validate the Boormans model (incorporating tumor size, rete testis invasion, and lymphovascular invasion) against the conventional classification (tumor size > 4 cm/rete testis invasion).
Andreas Banner, Eveline Daetwyler, Stefanie Fischer, Stephanie Schöpfer‐Schwab, Karl Pemberger, Michael Scholz, Kathrin Olesch, David Oswald, Angelina Strauch, Tim Nestler, Lukas Koren‐Wagner, Robin Zeder, Clemens Mikulits, Sebastian Lenart, Christoph Seidel, Angelika Terbuch   +15 more
wiley   +1 more source

Testicular cancer incidence and associations with prior epididymo-orchitis or urinary tract infections: a national cohort study in Sweden, 1964-2018. [PDF]

BMJ Oncol
Jansåker F, Li X, Sundquist K.
europepmc   +1 more source

Air Pollution and Cardiovascular Risks in Testicular Cancer Survivors: An Exploratory Case-Crossover Study. [PDF]

J Adolesc Young Adult Oncol
Ou JY, Ramsay JM, Kaddas HK, VanDerslice JA, O'Neil B, García SM, Horne BD, Hanson H, Kirchhoff AC.   +8 more
europepmc   +1 more source

Extreme Thrombocytosis in Patients With Malignancy; Complications, Management and Outcomes

eJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Extreme thrombocytosis (EXT; platelet count >1000 × 109/L) is a rare haematological abnormality that may be primary or reactive. Data on its incidence and management in patients with malignancy are limited. We retrospectively evaluated the incidence, management, and complications of EXT in patients with malignancy over a 12‐year ...
Laura McDonald, Heba Hasan, Lorelyn Donato, Lillie Wylde, Rifa Cardoso, Kevin Boyd, Rita Peralta, Sunil Iyengar, Dima El‐Sharkawi   +8 more
wiley   +1 more source

Testicular Cancer-Associated Paraneoplastic Neurologic Syndromes.

JAMA Netw Open
Harahsheh E, Hammami MB, Gupta P, Costello BA, Leibovich B, Cheville JC, Zekeridou A, McKeon A, Pittock SJ, Dubey D.   +9 more
europepmc   +1 more source

Factors Associated With Testicular Cancer Risk Among New American Military Recruits During Wartime. [PDF]

Am J Mens Health
Nelson DA, Hill OT, Skaggs SA, Brown WJ.
europepmc   +1 more source

Efficacy and Safety of Apixaban Thromboprophylaxis According to Baseline Chemotherapy Class in High‐Risk Ambulatory Cancer Patients: A Post Hoc Analysis of the AVERT Trial

Cancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in cancer patients. The AVERT trial showed apixaban thromboprophylaxis reduced VTE in intermediate‐to‐high‐risk patients initiating chemotherapy. However, the efficacy and safety of apixaban according to baseline chemotherapy class remain incompletely ...
Nadia Linxi Feng, John Doering, Tzu‐Fei Wang, Ranjeeta Mallick, Grégoire Le Gal, Joseph Shaw, Danny Hill, Sudeep Shivakumar, Vicky Tagalakis, Phil Wells, Marc Carrier   +10 more
wiley   +1 more source

Etoposide dosing challenges in a testicular cancer patient with hepatic impairment and drug-drug interactions-a case report. [PDF]

Cancer Chemother Pharmacol
Op 't Hoog CJP, de Jong LAW, Sijm J, Smits M, Mulder SF, Boerrigter E.   +5 more
europepmc   +1 more source